Stephen P Bergin

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Extracorporeal Membrane Oxygenation

End Stage Renal Disease

Prognostic Factors

Ejection Fraction

Top Venues

PharmacoEconomics

This page only lists publications with an associated author ORCID identifier.

Publications

Andrew John Sutton, Daniel S Lupu, Stephen P Bergin, Thomas L Holland, Staci A McAdams, Sanjeet Singh Dadwal, Khoi Nguyen, Frederick S Nolte, Gabriel Tremblay, Bradley A Perkins
Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia. PharmacoEconomics 42 (9) (2024)
Andrew John Sutton, Daniel S Lupu, Stephen P Bergin, Thomas L Holland, Staci A McAdams, Sanjeet Singh Dadwal, Khoi Nguyen, Frederick S Nolte, Gabriel Tremblay, Bradley A Perkins
Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia. PharmacoEconomics 42 (9) (2024)
Andrew John Sutton, Daniel S Lupu, Stephen P Bergin, Thomas L Holland, Staci A McAdams, Sanjeet Singh Dadwal, Khoi Nguyen, Frederick S Nolte, Gabriel Tremblay, Bradley A Perkins
Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia. PharmacoEconomics 42 (9) (2024)
Andrew John Sutton, Daniel S Lupu, Stephen P Bergin, Thomas L Holland, Staci A McAdams, Sanjeet Singh Dadwal, Khoi Nguyen, Frederick S Nolte, Gabriel Tremblay, Bradley A Perkins
Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia. PharmacoEconomics 42 (9) (2024)
Andrew John Sutton, Daniel S Lupu, Stephen P Bergin, Thomas L Holland, Staci A McAdams, Sanjeet Singh Dadwal, Khoi Nguyen, Frederick S Nolte, Gabriel Tremblay, Bradley A Perkins
Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia. PharmacoEconomics (2024)